Bayesian Capital Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,306	Closed	-$1.17M	–	980
2024 Q4	$1.17M	Buy	+3,306	New	+$1.22M	0.14%	211
2024 Q2	–	Sell	-3,360	Closed	-$772K	–	1115
2024 Q1	$772K	Buy	+3,360	New	+$758K	0.07%	340
2023 Q1	–	Sell	-1,542	Closed	-$429K	–	1104
2022 Q4	$429K	Buy	+1,542	New	+$389K	0.06%	396
2022 Q3	–	Sell	-9,500	Closed	-$2.24M	–	1031
2022 Q2	$2.24M	Buy	9,500 +7,800	+459%	+$1.59M	0.42%	32
2022 Q1	$305K	Buy	+1,700	New	+$324K	0.05%	514
2020 Q1	–	Sell	-2,621	Closed	-$231K	–	988
2019 Q4	$231K	Buy	+2,621	New	+$231K	0.04%	494
2019 Q3	–	Sell	-12,376	Closed	-$966K	–	697
2019 Q2	$966K	Buy	+12,376	New	+$1.16M	0.2%	146
2018 Q1	–	Sell	-4,600	Closed	-$681K	–	830
2017 Q4	$681K	Buy	+4,600	New	+$585K	0.14%	249
2016 Q1	–	Sell	-2,003	Closed	-$314K	–	446
2015 Q4	$314K	Buy	+2,003	New	+$292K	0.45%	88